Mineralys Therapeutics (MLYS) Q2 2026 Earnings

May 6Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.98
-0.81
-0.64
-0.47

Details

Expected EPS
-0.472157
Actual EPS
-0.47
Surprise EPS
0
Surprise Percent
+0.46%

Description

⁨Mineralys Therapeutics⁩ (⁦MLYS⁩) has reported earnings of ⁦-0.47⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts